Proton pump inhibitor and clopidogrel interaction: Have we forgotten aspirin?

British Journal of Haematology

Volumn 155, Issue 3, 2011, Pages 407-408

  Ali, Omer H ^a   Uzoigwe, Chika E ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b KETTERING GENERAL HOSPITAL   (United Kingdom)

Author keywords

Anticoagulation; Aspirin; Clopidogrel; PH; Proton pump inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PROTON PUMP INHIBITOR;

BODY TEMPERATURE; COMPETITIVE INHIBITION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG RESPONSE; DRUG SENSITIVITY; DRUG USE; HEART INFARCTION; HUMAN; HYDROPHILICITY; LETTER; LIPOPHILICITY; MATHEMATICAL MODEL; PRIORITY JOURNAL; RISK ASSESSMENT; STOMACH PH; THROMBOCYTE AGGREGATION INHIBITION;

ASPIRIN; DRUG INTERACTIONS; HUMANS; KINETICS; PROTON PUMP INHIBITORS; TICLOPIDINE;

EID: 80053934584     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08699.x     Document Type: Letter

References (8)

1. Charlot, M., Ahlehoff, O., Norgaard, M.L., Jorgensen, C.H., Sorensen, R., Abildstrom, S.Z., Hansen, P.R., Madsen, J.K., Kober, L., Torp-Pedersen, C. & Gislason, G. (2010) Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study. Annals of Internal Medicine, 153, 378-386.
2. Gardner, J.D., Sloan, S., Robinson, M. & Miner, P.B. Jr (2004) Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor. Alimentary Pharmacology and Therapeutics, 20, 1381-1386.
3. IMS Health. (2008) Top 15 Global Therapeutic Classes. Available from: Accessed 9 January 2011.
4. IMS Heath. (2009) Global Products, 2009, Total Audited Markets. Availble from:. Accessed 9 January 2011.
5. Juurlink, D.N., Gomes, T., Ko, D.T., Szmitko, P.E., Austin, P.C., Tu, J.V., Henry, D.A., Kopp, A. & Mamdani, M.M. (2009) A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. Canadian Medical Association Journal, 180, 713-718.
6. Maree, A.O., Curtin, R.J., Dooley, M., Conroy, R.M., Crean, P., Cox, D. & Fitzgerald, D.J. (2005) Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease. Journal of the American College of Cardiology, 46, 1258-1263.
7. Wurtz, M., Grove, E.L., Christensen, S.D. & Hvas, A.M. (2010) The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease. Heart, 96, 368-371.
8. Yusuf, S., Zhao, F., Mehta, S.R., Chrolavicius, S., Tognoni, G. & Fox, K.K. (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. New England Journal of Medicine, 345, 494-502.